Structure |
Chemical Name |
CAS |
MF |
|
Vorapaxar |
900161-12-8 |
C29H34N2O5 |
|
tert-butyl 4,4-Dimethyl-2,2-dioxooxathiazolidine-3-carboxylate |
454248-55-6 |
C9H17NO5S |
|
1-BOC-4-(4-FLUORO-PHENYLAMINO)-PIPERIDINE |
288573-56-8 |
C16H23FN2O2 |
|
(r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
863453-61-6 |
C8H15NO5S |
|
tert-butyl (2S)-2-(hydroxymethyl)-2-methylpyrrolidine-1-carboxylate |
1339022-10-4 |
C11H21NO3 |
|
1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- |
491833-28-4 |
C15H22N2O3 |
|
tert-butyl 4-(3-(methoxycarbonyl)phenyl)piperidine-1-carboxylate |
1016980-41-8 |
C18H25NO4 |
|
[3,3']Biazetidinyl-1-carboxylicacidtert-butylester |
1251018-87-7 |
C11H20N2O2 |
|
4-(Bromomethyl)-7-(diethylamino)coumarin |
1256259-14-9 |
C14H16BrNO2 |
|
TERT-BUTYL 3-((2-ETHOXY-2-OXOETHYL)SULFONYL)AZETIDINE-1-CARBOXYLATE |
1648864-57-6 |
C12H21NO6S |
|
2-Oxo-1-benzimidazolinebutyric Acid |
3273-68-5 |
C11H12N2O3 |
|
(1S,2R)-METHYL 2-(2-HYDROXYETHYL)CYCLOPROPANECARBOXYLATE |
2165933-01-5 |
C7H12O3 |
|
1-Piperazinecarboxylic acid, 3,5-diMethyl-, 1,1-diMethylethyl ester, (3S,5S)- |
888327-50-2 |
C11H22N2O2 |
|
(1S,3R,4S)-Ethyl 4-AMino-3-((tert-butoxycarbonyl)aMino)cyclohexanecarboxylate Oxalate |
1093351-24-6 |
C16H28N2O8 |
|
[3S-[3alpha(S*),5alpha]]-3-[[5-(2,4-Difluorophenyl)tetrahydro-5-(iodomethyl)-3-furanyl]carbonyl]-4-(phenylmethyl)-2-oxazolidinone |
165115-89-9 |
C22H20F2INO4 |
|
7-(Diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one |
54711-38-5 |
C14H17NO3 |
|
N-Deformyl-N-pivaloyl Orlistat |
1356017-35-0 |
C33H61NO5 |
|
2'-O-(2-Methoxyethyl)cytidine |
223777-16-0 |
C12H19N3O6 |
|
2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate |
1180002-01-0 |
C15H23N3O4 |
|
Ethyl N-Cbz-4-Oxopyrrolidine-3-carboxylate |
51814-19-8 |
C15H17NO5 |
|
lupinine hydrochloride |
6113-09-3 |
C10H20ClNO |
|
METHYL ESTER, 4,5-BIS(2-METHOXYETHOXY)-2-NITROBENZOIC ACID |
501684-22-6 |
C14H19NO8 |
|
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
179324-87-9 |
C17H29BF3NO4 |
|
TERT-BUTYL 3-BROMO-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-7(8H)-CARBOXYLATE |
723286-80-4 |
C10H15BrN4O2 |
|
1-Boc-2,5-Dihydro-1H-pyrrole-3-boronic acid, pinacol ester |
212127-83-8 |
C15H26BNO4 |
|
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
153004-31-0 |
C32H47F5O2S |
|
(1R,4S,4aR,9aS)-rel-1,4,4a,9a-Tetrahydro-4a-methyl-1,4-methanoanthracene-9,10-dione |
97804-50-7 |
C16H14O2 |
|
6-Chloro-1H-pyrazolo[4,3-c]pyridine |
1206979-33-0 |
C6H4ClN3 |
|
TFA-ap-dC |
115899-38-2 |
C14H15F3N4O5 |
|
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
521284-22-0 |
C16H21ClN2O |
|
(R)-tert-butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate |
877399-51-4 |
C26H30Cl2FN5O3 |
|
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine |
133111-56-5 |
C21H20ClN |
|
3-Iodo-1H-pyrazole-4-carbonitrile |
827316-44-9 |
C4H2IN3 |
|
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) |
247068-81-1 |
C14H25NO3 |
|
interMediates of eletriptan hydrobroMide |
180637-88-1 |
C24H26N2O3S |
|
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone hydrochloride |
37951-53-4 |
C13H20ClNO2 |
|
tert-butyl (R)-4-(((tert-butyldimethylsilyl)oxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
|
|
|
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
211105-29-2 |
C20H28D4O5 |
|
(S)-3-PHENYL-BETA-ALANINOL HCL
|
936499-93-3 |
C9H14ClNO |
|
Entecavir hydrate |
|
|
|
3-Piperidinecarboxylicacid,2-methyl-,methylester(9CI) |
183786-23-4 |
C8H15NO2 |
|
4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid |
130525-62-1 |
C11H18N2O7 |
|
4-(4-HYDROXYPHENYL)BUTANOIC ACID |
7021-11-6 |
C10H12O3 |
|
4-Fluoro-1H-pyrazole |
35277-02-2 |
C3H3FN2 |
|
METHYL 1H-PYRAZOLE-4-CARBOXYLATE |
51105-90-9 |
C5H6N2O2 |
|
2-(2-HYDROXYPHENYL)-4H-1,3-BENZOXAZIN-4-ONE |
1218-69-5 |
C14H9NO3 |
|
3-Methylpyrazole |
1453-58-3 |
C4H6N2 |
|
2-Cyanobenzyl bromide |
22115-41-9 |
C8H6BrN |
|
(2S,4S)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
168263-82-9 |
C11H20N2O4 |
|
1,4-pentadiyn-3-ol |
56598-53-9 |
C5H4O |
|
Nilotinib Hydrochloride Monohydrate |
923288-90-8 |
C28H25ClF3N7O2 |
|
4-Morpholinyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride |
1220027-05-3 |
C11H17ClN4O2 |
|
2-(Diethylamino)-N'-hydroxybenzenecarboximidamide |
1021244-00-7 |
C11H17N3O |
|
tert-butyl 8-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate |
1251009-03-6 |
C12H20N2O3 |
|
pinanyl hydroperoxide |
28324-52-9 |
C10H18O2 |
|
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
76247-39-7 |
C9H12INO5S |
|
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
|
8-bromoxanthosine |
3001-46-5 |
C10H11BrN4O6 |
|
Amic acid |
|
|
|
(3R)-3-dodecanoyloxy-4-trimethylammonio-butanoate |
25518-54-1 |
C19H37NO4 |
|
ATORVASTATIN SODIUM |
134523-01-6 |
C33H36FN2NaO5 |
|
N(4)-methylcytidine |
10578-79-7 |
C10H15N3O5 |
|
qianhucoumarin A |
150135-35-6 |
C19H20O6 |
|
Posaconazole EnantioMer |
|
|
|
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid |
483340-19-8 |
C13H13F2N3O3 |
|
6-[[[4-[(1-Oxo-2-propen-1-yl)oxy]butoxy]carbonyl]oxy]-2-naphthalenecarboxylic acid 2,2'-[2-(methoxycarbonyl)-1,4-phenylene] ester |
914918-26-6 |
C46H40O16 |
|
Methyl 1-(MethylaMino)cyclobutanecarboxylate hydrochloride |
1247180-93-3 |
C7H13NO2 |
|
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester |
112811-71-9 |
C16H15F2NO4 |
|
tert-butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate |
1246551-25-6 |
C11H19N3O3 |
|
Velpatasvir intermediate |
1378391-43-5 |
C44H55N3O13 |
|
Safinamide-d4 |
1147299-69-1 |
C17H19FN2O2 |
|
tert-butyl 4-(chloromethyl)-4-(hydroxymethyl)piperidine-1-carboxylate |
1312131-45-5 |
C12H22ClNO3 |
|
Posaconazole Diastereoisomer 12 |
213381-04-5 |
C37H42F2N8O4 |
|
tert-butyl(R)-3-((6-chloropyrazin-2-yl)oxy)piperidine-1-carboxylate |
1147998-31-9 |
C14H20ClN3O3 |
|
1-[4-Bromo-3-(bromomethyl)phenyl]ethanone |
1844064-91-0 |
C9H8Br2O |
|
3-Aminopyrazole |
1820-80-0 |
C3H5N3 |
|
Cefuroxime double mother nucleus |
|
|
|
Derivatives intermediate 2 |
1213710-57-6 |
C26H38N2O3 |
|
Hydantoin |
461-72-3 |
C3H4N2O2 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-98-8 |
C37H42F2N8O4 |
|
17-PHENYL TRINOR PROSTAGLANDIN E2 |
38315-43-4 |
C23H30O5 |
|
PROSTAGLANDIN D2 |
41598-07-6 |
C20H32O5 |
|
3-cinnamoyl-4-hydroxy-2H -chromen-2-one |
209973-90-0 |
C18H12O4 |
|
Sugammadex sodium 7-Bromide intermediates |
|
|
|
Oseltamivir Glucose Adduct 1 |
|
|
|
(3R,5R,2R,3S)-posaconazole |
|
|
|
7-HYDROXY-4-PHENYLCOUMARIN 97 |
2555-30-8 |
C15H10O3 |
|
ditert-butyl pyrrolidine-1,2-dicarboxylate |
347189-18-8 |
C14H25NO4 |
|
Remdesivir No. 5 intermediate |
|
|
|
Dextran Standard D0 |
|
|
|
Cefotifuromercapto |
|
|
|
tert-butyl 2-(5-bromo-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonane-7-carboxylate |
|
|
|
BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER |
57113-90-3 |
C13H16N2O6 |
|
tert-butyl (S)-(1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)carbamate |
2377357-06-5 |
C18H26N2O2 |
|
4-Oxazolecarboxylic acid, 5-amino-, methyl ester |
63820-04-2 |
C5H6N2O3 |
|
2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester |
191790-79-1 |
C15H21NO2 |
|
(9H-fluoren-9-yl)methyl (R)-(1-(methylamino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(1-cyclohexyl-2-(methylamino)-2-oxoethyl)carbamate |
|
|
|
Cephalexin Tablets |
|
|
|
Pluronic PE 4300 |
|
|